Longstaff C, Gaffney P J
Division of Haematology, National Institute for Biological Standards and Control, Hertfordshire, UK.
Blood Coagul Fibrinolysis. 1992 Feb;3(1):89-97. doi: 10.1097/00001721-199202000-00013.
The serpin family of inhibitors have an important role in the control of coagulation and fibrinolysis. For a full understanding of how these pathways operate in vivo and correct measurement of enzyme and inhibitor activity, in vitro knowledge of the mechanism of action of serpins is essential. Using alpha 2-antiplasmin as a model inhibitor we find, in contrast to most previous reports, a reversible mechanism: E + I in equilibrium with EI in equilibrium with EI', where complex formation is two stepped, but both steps are reversible. Our work with plasmin in the presence of 50 mM aminohexanoic acid shows that binding of alpha 2-antiplasmin is very tight (but reversible) with an overall Ki (Ki final) = 4.0 pM. With chymotrypsin (a model serine protease) Ki final = 100 pM, so as expected binding of alpha 2-antiplasmin is weaker with chymotrypsin. However, analysis of the individual rate constants shows that the difference in strength of binding is accounted for by the dissociation rate constant for the second step (k-2) = 1.9 x 10(-6) s-1 for plasmin and 1.1 x 10(-4) s-1 for chymotrypsin. Thus k-2, the rate constant previously ignored, explains the different affinities of alpha 2-antiplasmin for these two enzymes. Furthermore, this model of two (or more) step, reversible binding is accepted for protease inhibitors of other families. With one of these, aprotinin (a Kunitz inhibitor) with plasmin we also obtain a two-stage reversible mechanism with a Ki final = 200 pM and the strength of inhibition is also largely determined by k-2 = 3.5 x 10(-5) s-1.(ABSTRACT TRUNCATED AT 250 WORDS)
丝氨酸蛋白酶抑制剂(serpin)家族的抑制剂在凝血和纤维蛋白溶解的控制中起着重要作用。为了全面了解这些途径在体内的运作方式以及准确测量酶和抑制剂的活性,体外了解serpin的作用机制至关重要。以α2-抗纤溶酶作为模型抑制剂,我们发现,与大多数先前的报道相反,其作用机制是可逆的:E + I与EI处于平衡状态,EI与EI'处于平衡状态,其中复合物的形成是分两步进行的,但两步都是可逆的。我们在50 mM氨基己酸存在的情况下对纤溶酶的研究表明,α2-抗纤溶酶的结合非常紧密(但可逆),总体Ki(最终Ki)= 4.0 pM。对于胰凝乳蛋白酶(一种典型的丝氨酸蛋白酶),最终Ki = 100 pM,因此正如预期的那样,α2-抗纤溶酶与胰凝乳蛋白酶的结合较弱。然而,对各个速率常数的分析表明,结合强度的差异是由第二步的解离速率常数(k-2)造成的:纤溶酶的k-2 = 1.9×10(-6)s-1,胰凝乳蛋白酶的k-2 = 1.1×10(-4)s-1。因此,之前被忽视的速率常数k-2解释了α2-抗纤溶酶对这两种酶的不同亲和力。此外,这种两步(或更多步)可逆结合的模型也适用于其他家族的蛋白酶抑制剂。对于其中一种,抑肽酶(一种库尼兹抑制剂)与纤溶酶,我们也得到了一种两阶段可逆机制,最终Ki = 200 pM,抑制强度也很大程度上由k-2 = 3.5×10(-5)s-1决定。(摘要截断于250字)